|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
24,740,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.35 - $0.35 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cox Geoffrey F |
President, CEO and Chairman |
|
2007-01-05 |
4 |
A |
$0.94 |
$1,189 |
D/D |
1,260 |
204,694 |
|
- |
|
Lfb Biotechnologies S.a.s.u. |
10% Owner |
|
2007-01-03 |
4 |
B |
$1.23 |
$4,464,900 |
D/D |
3,630,000 |
3,630,000 |
2.45 |
- |
|
Bechon Christian |
Director |
|
2007-01-03 |
4 |
B |
$1.23 |
$4,464,900 |
I/I |
3,630,000 |
3,630,000 |
2.1 |
- |
|
Mcnamara Pamela W |
Director |
|
2006-12-29 |
4 |
A |
$1.11 |
$1,000 |
D/D |
901 |
4,701 |
|
- |
|
Geraghty James A |
Director |
|
2006-12-29 |
4 |
A |
$1.11 |
$1,750 |
D/D |
1,577 |
66,989 |
|
- |
|
Miller Marvin |
Director |
|
2006-12-29 |
4 |
A |
$1.11 |
$800 |
D/D |
721 |
3,850 |
|
- |
|
Bullock Francis J |
Director |
|
2006-12-29 |
4/A |
B |
$1.11 |
$1,875 |
D/D |
1,689 |
3,201 |
2.31 |
- |
|
Tuck Alan W |
Director |
|
2006-12-29 |
4/A |
A |
$1.11 |
$1,000 |
D/D |
901 |
2,707 |
|
- |
|
Bullock Francis J |
Director |
|
2006-12-29 |
4 |
A |
$1.11 |
$1,875 |
D/D |
1,689 |
4,818 |
|
- |
|
Tuck Alan W |
Director |
|
2006-12-29 |
4 |
A |
$1.11 |
$1,000 |
D/D |
901 |
2,701 |
|
- |
|
Woloshen Daniel S |
Senior VP and General Counsel |
|
2006-12-22 |
4 |
AS |
$1.10 |
$8,221 |
D/D |
(7,500) |
64,134 |
|
- |
|
Cox Geoffrey F |
President, CEO and Chairman |
|
2006-11-06 |
4 |
B |
$1.05 |
$15,127 |
D/D |
14,300 |
203,434 |
2.81 |
- |
|
Scotland Richard A |
Senior VP, Regulatory Affairs |
|
2006-10-06 |
4 |
A |
$0.99 |
$1,253 |
D/D |
1,260 |
48,596 |
|
- |
|
Cox Geoffrey F |
President, CEO and Chairman |
|
2006-10-06 |
4 |
A |
$0.99 |
$1,168 |
D/D |
1,174 |
189,134 |
|
- |
|
Miller Marvin |
Director |
|
2006-09-29 |
4 |
A |
$1.24 |
$1,400 |
D/D |
1,129 |
3,129 |
|
- |
|
Geraghty James A |
Director |
|
2006-09-29 |
4 |
B |
$1.24 |
$3,250 |
D/D |
2,621 |
65,412 |
2.31 |
- |
|
Tuck Alan W |
Director |
|
2006-09-29 |
4 |
B |
$1.24 |
$992 |
D/D |
800 |
1,800 |
2.31 |
- |
|
Bullock Francis J |
Director |
|
2006-09-29 |
4/A |
B |
$1.24 |
$1,875 |
D/D |
1,512 |
1,512 |
2.31 |
- |
|
Tuck Alan W |
Director |
|
2006-09-29 |
4/A |
B |
$1.24 |
$999 |
D/D |
806 |
1,806 |
2.31 |
- |
|
Bullock Francis J |
Director |
|
2006-09-29 |
4 |
A |
$1.24 |
$1,400 |
D/D |
1,129 |
3,129 |
|
- |
|
Scotland Richard A |
Senior VP, Regulatory Affairs |
|
2006-08-10 |
4 |
A |
$1.23 |
$1,230 |
D/D |
1,000 |
47,336 |
|
- |
|
Meade Harry |
SVP, Transgenic Research |
|
2006-08-10 |
4 |
A |
$1.23 |
$1,230 |
D/D |
1,000 |
89,226 |
|
- |
|
Cox Geoffrey F |
President, CEO and Chairman |
|
2006-08-10 |
4 |
A |
$1.23 |
$1,230 |
D/D |
1,000 |
187,960 |
|
- |
|
Green John B |
Senior VP and CFO |
|
2006-08-10 |
4 |
A |
$1.23 |
$1,230 |
D/D |
1,000 |
85,700 |
|
- |
|
Liposky Gregory F |
Senior VP, Operations |
|
2006-08-10 |
4 |
D |
$1.23 |
$192 |
D/D |
(156) |
33,548 |
|
- |
|
213 Records found
|
|
Page 7 of 9 |
|
|